Atossa Therapeutics
ATOS
#10731
Rank
โ‚น2.26 B
Marketcap
โ‚น226.55
Share price
-2.86%
Change (1 day)
173.19%
Change (1 year)

Atossa Therapeutics (ATOS) - Net assets

Net assets on the balance sheet as of June 2026 : โ‚น2.55 Billion

According to Atossa Therapeutics's latest financial reports the company has โ‚น2.55 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$โ‚น3.53 B-42.39%
2024-12-31$โ‚น6.13 B-19.07%
2023-12-31$โ‚น7.57 B-22.38%
2022-12-31$โ‚น9.76 B-5.06%
2021-12-31$โ‚น10.28 B417.47%
2020-12-31$โ‚น1.98 B111.79%
2019-12-31$โ‚น0.93 B52.38%
2018-12-31$โ‚น0.61 B38.96%
2017-12-31$โ‚น0.44 B110.51%
2016-12-31$โ‚น0.21 B-15.36%
2015-12-31$โ‚น0.24 B-58.69%
2014-12-31$โ‚น0.60 B-8.09%
2013-12-31$โ‚น0.65 B131.13%
2012-12-31$โ‚น0.28 B243.45%
2011-12-31$โ‚น82.5 M-316.15%
2010-12-31$-โ‚น38.18 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
โ‚น8.088 T 316,601.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น751.90 B 29,340.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น820.84 B 32,040.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚น74.79 B 2,828.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚น4.13 B 61.75%๐Ÿ‡บ๐Ÿ‡ธ USA